Anxiety led to discontinuation of CONCERTA in some patients. It is recommended to monitor patients beginning treatment with CONCERTA for the appearance of, or
Dosage Reduction and Discontinuation If paradoxical aggravation of symptoms or other adverse reactions occur, reduce dosage or, if necessary, discontinue CONCERTA. If improvement is not observed after appropriate dosage adjustment over a one-month period, discontinue CONCERTA.
The Patriot Generic product is being discontinued by the end of January 2024. Methylphenidate (Concerta) Product Shortage in.
Concerta is currently protected by a patent that prevents any generic Concerta from being manufactured. The first patent for Concerta is set to expire in 2024.
CONCERTA must be discontinued as soon as possible if serotonin syndrome is suspected. CONCERTA was demonstrated to be effective in the treatment of
The Patriot Generic product is being discontinued by the end of January 2024. Patriot is a subsidiary of Janssen who is the maker of brand Concerta. This
Anxiety led to discontinuation of CONCERTA is some patients. It is recommended to monitor patients beginning treatment with CONCERTA for.
The Patriot Generic product is being discontinued by the end of January 2024. Patriot is a subsidiary of Janssen who is the maker of brand Concerta.
discontinued in January 2024 and Discontinuation of the authorized Patriot generic Concerta FDA guidelines have given generic
Comments